SIRT7 and breast carcinoma: In this study, we found that the expression of γH2AX, a marker of CIN, was significantly increased in the DOX treatment group, which was accompanied by the downregulated expression of SIRT7, simultaneous indication inhibits of SIRT7 expression and enhancement of CIN in breast cancer cells.